Cryoport Inc
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells offers cry… Read more
Cryoport Inc (CYRX) - Net Assets
Latest net assets as of December 2025: $502.64 Million USD
Based on the latest financial reports, Cryoport Inc (CYRX) has net assets worth $502.64 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($764.99 Million) and total liabilities ($262.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $502.64 Million |
| % of Total Assets | 65.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | -21.69% |
| 10-Year Change | 8748.63% |
| Growth Volatility | 112.12 |
Cryoport Inc - Net Assets Trend (2004–2025)
This chart illustrates how Cryoport Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cryoport Inc (2004–2025)
The table below shows the annual net assets of Cryoport Inc from 2004 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $502.64 Million | +25.07% |
| 2024-12-31 | $401.90 Million | -17.82% |
| 2023-12-31 | $489.02 Million | -12.02% |
| 2022-12-31 | $555.84 Million | -13.40% |
| 2021-12-31 | $641.83 Million | +67.71% |
| 2020-12-31 | $382.70 Million | +203.05% |
| 2019-12-31 | $126.28 Million | +227.61% |
| 2018-12-31 | $38.55 Million | +115.50% |
| 2017-12-31 | $17.89 Million | +214.89% |
| 2016-12-31 | $5.68 Million | +13.83% |
| 2015-12-31 | $4.99 Million | +1298.72% |
| 2014-12-31 | $-416.30K | +81.94% |
| 2013-12-31 | $-2.30 Million | -11.69% |
| 2012-12-31 | $-2.06 Million | -155.32% |
| 2011-12-31 | $3.73 Million | -37.30% |
| 2010-12-31 | $5.95 Million | +750.40% |
| 2009-12-31 | $-914.58K | +75.17% |
| 2008-12-31 | $-3.68 Million | -61.01% |
| 2007-12-31 | $-2.29 Million | -16.66% |
| 2006-12-31 | $-1.96 Million | +8.79% |
| 2005-12-31 | $-2.15 Million | -82.20% |
| 2004-12-31 | $-1.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cryoport Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 68336721000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $50.00K | 0.01% |
| Other Comprehensive Income | $-3.48 Million | -0.69% |
| Other Components | $1.19 Billion | 237.74% |
| Total Equity | $502.64 Million | 100.00% |
Cryoport Inc Competitors by Market Cap
The table below lists competitors of Cryoport Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Stef SA
PA:STF
|
$324.84 Million |
|
Zenitron Corp
TW:3028
|
$324.86 Million |
|
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
|
$324.87 Million |
|
Coca-Cola Embonor S.A
SN:EMBONOR-B
|
$324.89 Million |
|
Empresa Distribuidora y Comercializadora Norte S.A.
BA:EDN
|
$324.71 Million |
|
Xinjiang Baihuacun Co Ltd
SHG:600721
|
$324.62 Million |
|
Anhui Higasket Plastics Co.Ltd.
SHG:603150
|
$324.48 Million |
|
LiaonWellhope Agri-Tech Co Ltd
SHG:603609
|
$324.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cryoport Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 401,898,000 to 502,638,000, a change of 100,740,000 (25.1%).
- Net income of 70,301,000 contributed positively to equity growth.
- Dividend payments of 8,000,000 reduced retained earnings.
- Share repurchases of 10,011,000 reduced equity.
- Other comprehensive income increased equity by 17,446,000.
- Other factors increased equity by 31,004,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $70.30 Million | +13.99% |
| Dividends Paid | $8.00 Million | -1.59% |
| Share Repurchases | $10.01 Million | -1.99% |
| Other Comprehensive Income | $17.45 Million | +3.47% |
| Other Changes | $31.00 Million | +6.17% |
| Total Change | $- | 25.07% |
Book Value vs Market Value Analysis
This analysis compares Cryoport Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.81x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | $-7.38 | $8.12 | x |
| 2006-12-31 | $-7.35 | $8.12 | x |
| 2007-12-31 | $-8.28 | $8.12 | x |
| 2008-12-31 | $-10.00 | $8.12 | x |
| 2009-12-31 | $-2.04 | $8.12 | x |
| 2010-12-31 | $5.01 | $8.12 | x |
| 2011-12-31 | $1.44 | $8.12 | x |
| 2012-12-31 | $-0.61 | $8.12 | x |
| 2013-12-31 | $-0.53 | $8.12 | x |
| 2014-12-31 | $-0.08 | $8.12 | x |
| 2015-12-31 | $0.63 | $8.12 | x |
| 2016-12-31 | $0.40 | $8.12 | x |
| 2017-12-31 | $0.78 | $8.12 | x |
| 2018-12-31 | $1.37 | $8.12 | x |
| 2019-12-31 | $3.78 | $8.12 | x |
| 2020-12-31 | $9.92 | $8.12 | x |
| 2021-12-31 | $13.97 | $8.12 | x |
| 2022-12-31 | $12.10 | $8.12 | x |
| 2023-12-31 | $9.98 | $8.12 | x |
| 2024-12-31 | $8.25 | $8.12 | x |
| 2025-12-31 | $10.04 | $8.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cryoport Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.99%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 39.90%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 1.52x
- Recent ROE (13.99%) is above the historical average (-44.95%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 0.00% | -382.46% | 0.25x | 0.00x | $-920.11K |
| 2006 | 0.00% | -999.42% | 0.40x | 0.00x | $-1.33 Million |
| 2007 | 0.00% | -3466.70% | 0.14x | 0.00x | $-2.10 Million |
| 2008 | 0.00% | -47560.50% | 0.02x | 0.00x | $-16.34 Million |
| 2009 | 0.00% | -4791.25% | 0.02x | 0.00x | $-5.56 Million |
| 2010 | -103.43% | -1293.84% | 0.04x | 1.85x | $-6.75 Million |
| 2011 | -210.03% | -1409.72% | 0.09x | 1.67x | $-8.21 Million |
| 2012 | 0.00% | -579.94% | 0.63x | 0.00x | $-6.18 Million |
| 2013 | 0.00% | -735.56% | 1.56x | 0.00x | $-19.33 Million |
| 2014 | 0.00% | -178.56% | 1.51x | 0.00x | $-6.99 Million |
| 2015 | -196.79% | -166.95% | 0.79x | 1.49x | $-10.32 Million |
| 2016 | -230.85% | -170.77% | 0.95x | 1.43x | $-13.68 Million |
| 2017 | -44.16% | -66.08% | 0.59x | 1.13x | $-9.69 Million |
| 2018 | -24.79% | -48.69% | 0.35x | 1.47x | $-13.41 Million |
| 2019 | -14.52% | -54.01% | 0.25x | 1.08x | $-30.96 Million |
| 2020 | -8.54% | -41.54% | 0.14x | 1.44x | $-70.96 Million |
| 2021 | -42.93% | -123.77% | 0.20x | 1.73x | $-339.71 Million |
| 2022 | -49.57% | -123.77% | 0.21x | 1.87x | $-331.11 Million |
| 2023 | -7.63% | -15.73% | 0.25x | 1.96x | $-86.24 Million |
| 2024 | -24.78% | -42.69% | 0.33x | 1.75x | $-139.78 Million |
| 2025 | 13.99% | 39.90% | 0.23x | 1.52x | $20.04 Million |
Industry Comparison
This section compares Cryoport Inc's net assets metrics with peer companies in the Integrated Freight & Logistics industry.
Industry Context
- Industry: Integrated Freight & Logistics
- Average net assets among peers: $365,352,726
- Average return on equity (ROE) among peers: 5.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cryoport Inc (CYRX) | $502.64 Million | 0.00% | 0.52x | $324.80 Million |
| Andlauer Healthcare Group Inc (ANDHF) | $167.54 Million | 12.94% | 0.60x | $469.38 Million |
| Aqua Power Systems Inc (APSI) | $-1.71 Million | 0.00% | 0.00x | $383.65K |
| A-Sonic Aerospace Limited (ASNCF) | $23.63 Million | -5.17% | 2.18x | $7.03 Million |
| Addentax Group Corp (ATXG) | $26.05 Million | -11.94% | 1.01x | $3.16 Million |
| bpost SA/NV (BPOSF) | $682.60 Million | 22.59% | 4.53x | $472.00 Million |
| Armlogi Holding Corp. Common Stock (BTOC) | $25.09 Million | -61.17% | 5.78x | $4.01 Million |
| Compañía de Distribución Integral Logista Holdings S.A (CDNIF) | $641.80 Million | 48.03% | 11.59x | $1.70 Billion |
| Cargojet Inc (CGJTF) | $66.60 Million | 3.60% | 5.94x | $791.09 Million |
| CH Robinson Worldwide Inc (CHRW) | $2.02 Billion | 41.75% | 2.48x | $20.09 Billion |
| Tianci International, Inc. Common Stock (CIIT) | $-9.14K | 0.00% | 0.00x | $14.82 Million |